Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzimidazole SCHEMBL5404384 | 0.89 | PRKCI (0.52) | PRKCIKDM4EALDH1A1MAPTTDP1 | |
| Benzimidazole SCHEMBL461969 | 0.89 | SMN1; SMN2 (0.50) | PRKCIKDM4EALDH1A1MAPTTDP1 | |
| Benzimidazole SCHEMBL29408372 | 0.89 | — | — | |
| Benzimidazole SCHEMBL6009 | 0.89 | — | — | |
| Benzimidazole SCHEMBL10931770 | 0.89 | SMN1; SMN2 (0.50) | PRKCIKDM4EALDH1A1MAPTTDP1 | |
| Benzimidazole SCHEMBL29358377 | 0.89 | — | — | |
| Benzimidazole SCHEMBL6583805 | 0.88 | PRKCI (0.62) | PRKCIKDM4EALDH1A1MAPTTDP1 | |
| Benzimidazole SCHEMBL2334176 | 0.87 | PRKCI (0.50) | PRKCIKDM4EALDH1A1MAPTTDP1 | |
| Benzimidazole SCHEMBL23673327 | 0.87 | SMN1; SMN2 (0.48) | PRKCIKDM4EALDH1A1MAPTTDP1 | |
| Benzimidazole SCHEMBL20531480 | 0.87 | SMN1; SMN2 (0.48) | PRKCIKDM4EALDH1A1MAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101084235-A | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS INC (US) | 2007-12-05 | — | — | CN | claimed |
| EP-0777656-B1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOC O (NZ) | 2004-04-14 | — | — | EP | claimed |
| US-5968933-A | ANTITUMOR AGENTS AND BINDING DNA FOR MUTAGENESIS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1999-10-19 | — | — | US | claimed |
| EP-0777656-A4 | NOVEL DNA-TARGETED ALKYLATING AGENTS | CANCER SOC AUCKLAND DIV NZ INC (NZ) | 1998-04-15 | — | — | EP | claimed |
| EP-0777656-A1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND (INCORPORATED) (NZ) | 1997-06-11 | — | — | EP | claimed |
| WO-1996006831-A1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1996-03-07 | — | — | WO | claimed |
| CN-101084235-B | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS INC | 2012-10-17 | — | — | CN | disclosed |
| CN-101084235-A | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS INC (US) | 2007-12-05 | — | — | CN | disclosed |
| EP-0777656-B1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOC O (NZ) | 2004-04-14 | — | — | EP | disclosed |
| EP-1387680-A1 | BENZIMIDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS | TransTech Pharma Inc. (US) | 2004-02-11 | — | — | EP | disclosed |
| WO-2002069965-A1 | BENZIMIDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS | TRANSTECH PHARMA, INC. (US) | 2002-09-12 | — | — | WO | disclosed |
| US-5968933-A | ANTITUMOR AGENTS AND BINDING DNA FOR MUTAGENESIS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1999-10-19 | — | — | US | disclosed |
| EP-0777656-A4 | NOVEL DNA-TARGETED ALKYLATING AGENTS | CANCER SOC AUCKLAND DIV NZ INC (NZ) | 1998-04-15 | — | — | EP | disclosed |
| EP-0777656-A1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND (INCORPORATED) (NZ) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996006831-A1 | NOVEL DNA-TARGETED ALKYLATING AGENTS | AUCKLAND DIVISION CANCER SOCIETY OF NEW ZEALAND INC. (NZ) | 1996-03-07 | — | — | WO | disclosed |